About Arbor Biosciences
Arbor Biosciences is a company based in Detroit (United States) founded in 2006 by Erdogan Gulari and Jean-Marie Rouillard was acquired by Chiral Technologies in January 2019. Arbor Biosciences offers products and services including myBaits Custom Hybridization Capture Kits, myBaits Predesigned Kits, myTXTL Pro Kit, myTags Custom Probes, and Sequencing Services. Arbor Biosciences operates in a competitive market with competitors including Inflammatix, Agendia, PathogenDX, KromaTiD and InDevR, among others.
- Headquarter Detroit, United States
- Founders Erdogan Gulari, Jean-Marie Rouillard
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biodiscovery Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$1.41 M (USD), Grant
Sep 24, 2012
-
Investors
HHS
& 2 more
-
Employee Count
Not available
-
Acquired by
Chiral Technologies
(Jan 10, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Arbor Biosciences
Arbor Biosciences offers a comprehensive portfolio of products and services, including myBaits Custom Hybridization Capture Kits, myBaits Predesigned Kits, myTXTL Pro Kit, myTags Custom Probes, and Sequencing Services.
Kits for custom capture in sequencing applications
Pre-designed kits for specific sequencing needs
Kit for protein synthesis in research contexts
Probes for in situ hybridization techniques
Services for DNA sequencing and analysis support
People of Arbor Biosciences
Unlock access to complete
Sales and Marketing
3 people
Customer Team
1 people
Software Development Team
1 people
Leadership Team
1 people
Unlock access to complete
Funding Insights of Arbor Biosciences
Investors in Arbor Biosciences
Arbor Biosciences has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include HHS, Daicel and Chiral Technologies.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Specialty chemicals are produced by Daicel in Japan since 1919.
|
Locked | Locked | Locked | |
|
Advanced chirality products and custom purification services
|
Locked | Locked | Locked |
Investor details for Arbor Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Arbor Biosciences
Investment portfolio details for Arbor Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Arbor Biosciences
Detailed financials for Arbor Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Arbor Biosciences Comparisons
Peer comparison for Arbor Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Arbor Biosciences
Arbor Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Agendia, PathogenDX, KromaTiD and InDevR, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of diagnostic solutions for systemic infections
|
|
| Locked | Locked | Locked |
Genomic diagnostic products for cancer treatment are provided.
|
|
| Locked | Locked | Locked |
Provider of DNA-based pathogen testing kits
|
|
| Locked | Locked | Locked |
Molecular and genetic tests for detecting disease-causing mutations are provided.
|
|
| Locked | Locked | Locked |
Biotherapeutics, vaccines, and diagnostic products are manufactured and developed.
|
|
| Locked | Locked | Locked |
Genomic tests for urologic cancers are developed and commercialized.
|
Detailed competitors of Arbor Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Arbor Biosciences
Complete news archive for Arbor Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Arbor Biosciences
Arbor Biosciences was founded in 2006.
Arbor Biosciences is headquartered in Detroit, United States. It is registered at Detroit, Michigan, United States.
Arbor Biosciences was founded in 2006 and is based in Detroit, United States. Operations focus on the biotechnology sector, where microarrays for DNA analysis are developed and supplied. The portfolio encompasses custom-designed microarrays known as myArray, in-solution target enrichment via myBaits, customizable DNA through myCRISPR, error-free DNA with myDNA, and oligonucleotide library synthesis using myLib. These offerings support applications in agrigenomics, cell-free protein expression, genome editing, paleogenetics, and phylogenetics.
Arbor Biosciences's top competitors include Inflammatix, PathogenDX and Agendia.
Arbor Biosciences offers myBaits Custom Hybridization Capture Kits, myBaits Predesigned Kits, myTXTL Pro Kit, myTags Custom Probes, and Sequencing Services.
Arbor Biosciences has 3 investors. Key investors include HHS, Daicel, and Chiral Technologies.